UCB Overview
Upcoming Projects (UCB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (UCB)
-
Third View: Discussing Current Treatment Landscape and use of Bimzelx for Patients with Psoriasis.
Ticker: UCB
Executed On: Nov 18, 2024 at 06:00 PM EST -
Second View: Discussing Current Treatment Landscape and use of Bimzelx for Patients with Psoriasis.
Ticker: UCB
Executed On: Oct 30, 2024 at 05:00 PM EDT -
A Third Look: Discussing the standard of care and the potential of NAYZILAM (midazolam), a nasal spray able to return patients experiencing seizure clusters back to baseline function within 90 minutes
Ticker: UCB
Executed On: Nov 28, 2023 at 08:30 AM EST -
A third look at FDA approved BIMZELX® (bimekizumab) for moderate to severe plaque psoriasis patients who are candidates for systemic therapy or phototherapy.
Ticker: UCB
Executed On: Nov 21, 2023 at 06:30 PM EST -
A second look at FDA approved BIMZELX® (bimekizumab) for moderate to severe plaque psoriasis patients who are candidates for systemic therapy or phototherapy.
Ticker: UCB
Executed On: Nov 21, 2023 at 05:00 PM EST -
A Second Look: Discussing the standard of care and the potential of NAYZILAM (midazolam), a nasal spray able to return patients experiencing seizure clusters back to baseline function within 90 minutes
Ticker: UCB
Executed On: Nov 21, 2023 at 02:00 PM EST -
Discussing the standard of care and the potential of NAYZILAM (midazolam), a nasal spray able to return patients experiencing seizure clusters back to baseline function within 90 minutes
Ticker: UCB
Executed On: Nov 17, 2023 at 01:30 PM EST -
A look at FDA approved BIMZELX® (bimekizumab) for moderate to severe plaque psoriasis patients who are candidates for systemic therapy or phototherapy.
Ticker: UCB
Executed On: Nov 03, 2023 at 11:30 AM EDT -
Checking on use of Epidiolex and Fintepla in the real world
Tickers: JAZZ, UCB
Executed On: May 10, 2022 at 11:00 AM EDT -
Discussing the epilepsy offerings from UCB (Vimpat, Keppra, Briviact, Nayzilam). - 2nd look
Ticker: UCB
Executed On: Jan 07, 2022 at 02:00 PM EST -
Discussing the epilepsy offerings from UCB (Vimpat, Keppra, Briviact, Nayzilam).
Ticker: UCB
Executed On: Jan 06, 2022 at 04:00 PM EST
Upcoming & Overdue Catalysts (UCB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (UCB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
